Enregistrement :
25
de
40
(2020-01-06
à
2020-04-15)
Politique ou Programme
Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries
Health Canada’s policies, program and guidelines related to the management, prevention, mitigation and notification of drug shortages
Patented Medicine Prices Review Board (PMPRB)consultation on the proposed modernization of the Compendium of Policies, Guidelines and Procedures
The Department of Innovation, Science and Economic Development and its Innovation Agenda for the life sciences sector: policy or program initiatives to support life science Research and Development conducted in Canada
Politique ou Programme, Proposition législative, Projet de loi ou résolution, Règlement
Consider amendments to the Food and Drugs Act, or the Export and Imports Permits Act (Export Control List) or any other legislative and regulatory means in order to protect the Canadian supply of drugs in light of potential importation legislation in the United States.
Politique ou Programme, Règlement
Regulations, policies and programs related to the reimbursement recommendations decision-making process and framework done by the Canadian Agency for Drugs and Technologies in Health (CADTH)/Common Drug Review as well as the review times and processes conducted by Health Canada for the purpuse of obtaining a notice of compliance.
Subsequent Entry Biologics (SEBs) and Orphan Drugs framework: seeking an approval framework supported and protected by Regulations in harmonization with other developed countries
Proposition législative, Projet de loi ou résolution, Règlement
Patent Act and the Intellectual property provisions as it relates to the adoption, ratification and eventual implementation of the Bill C-100, An Act to implement the Agreement between Canada, the United States of America and the United Mexican States Intellectual property protection provisions.
Règlement
Proposed modernization of the Patented Medicines Prices Review Board (PMPRB) Regulations in the consultation document “Protecting Canadians from Excessive Drug Prices”
Subvention, Contribution ou autre avantage financier
National Immunization Strategy. Advocacy to seek continued funding in vaccines.